Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Brigitta Bernát"'
Autor:
Arnold Péter Ráduly, Fruzsina Sárkány, Máté Balázs Kovács, Brigitta Bernát, Béla Juhász, Zoltán Szilvássy, Róbert Porszász, Balázs Horváth, Norbert Szentandrássy, Péter Nánási, Zoltán Csanádi, István Édes, Attila Tóth, Zoltán Papp, Dániel Priksz, Attila Borbély
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 1; Pages: 446
Recent cardiotropic drug developments have focused on cardiac myofilaments. Danicamtiv, the second direct myosin activator, has achieved encouraging results in preclinical and clinical studies, thus implicating its potential applicability in the trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73e130edbe5b7410ef4a9479e7fd7059
Autor:
Mohammad Walid Al-Smadi, Laszlo Adam Fazekas, Siran Aslan, Brigitta Bernat, Anas Beqain, Mustafa Qais Muhsin Al-Khafaji, Daniel Priksz, Brigitta Orlik, Norbert Nemeth
Publikováno v:
Biomedicines, Vol 11, Iss 11, p 2970 (2023)
Arteriovenous malformation (AVM) is an anomaly of blood vessel formation. Numerous models have been established to understand the nature of AVM. These models have limitations in terms of the diameter of the vessels used and the impact on the circulat
Externí odkaz:
https://doaj.org/article/ce0dc1b3b8c04a11b013e86160d8a430
Autor:
Brigitta Bernat, Rita Erdelyi, Laszlo Fazekas, Greta Garami, Reka Maria Szekeres, Barbara Takacs, Mariann Bombicz, Balazs Varga, Fruzsina Sarkany, Arnold Peter Raduly, Dana Diana Romanescu, Zoltan Papp, Attila Toth, Zoltan Szilvassy, Bela Juhasz, Daniel Priksz
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 359 (2023)
Multi-target drug candidate BGP-15 has shown cardioprotective and antiarrhythmic actions in diseased models. Here, we investigated the effects of BGP-15 on ECG and echocardiographic parameters, heart rate variability (HRV), and arrhythmia incidence i
Externí odkaz:
https://doaj.org/article/7ca9d4e1689c4d959f45995e5fae7db7